BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05256290-completion@plaintrial.com
DTSTAMP:20261027T055553Z
DTSTART;VALUE=DATE:202606
SUMMARY:Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Gliobl
 astoma or Non-Small Cell Lung Cancer With EGFR Mutations — estimated com
 pletion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05256290
URL:https://plaintrial.com/trial/NCT05256290
END:VEVENT
END:VCALENDAR